VEGFA and diabetic retinopathy: Bone marrow MSC-Exos attenuated oxidative stress and inflammation in diabetic retinopathy by inhibiting the Wnt, β-catenin pathway, upregulating superoxide dismutase (SOD), and suppressing VEGF-driven pathological neovascularization (Ebrahim et al. 2022).